← Back to Search
Other
Brain Stimulation + Behavioral Intervention for Motor Skill Learning (MEM_MOD Trial)
Charleston, SC
N/A
Recruiting
Led By Kirstin-Friederike Heise, PhD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before - after one single intervention (24 hour follow-up)
Summary
This trial tests if brain stimulation can help relearn motor skills, like posture in golf or piano playing, and if it can help those with chronic pain or after a stroke.
See full description
Who is the study for?
This trial is for healthy adults who can use a computer with internet, are 18 or older (with two-thirds being over 60), and can give consent. It's not for pregnant individuals, those with head injuries, brain conditions, metal in the head/neck, severe claustrophobia, neurological disorders, history of seizures or certain medications.
What is being tested?
The study tests if non-invasive brain stimulation (tACS) combined with behavioral tasks can change existing motor memories and aid new skill learning. Participants will also receive sham stimulation as a comparison while their brain activity is monitored using EEG.See study design
What are the potential side effects?
Potential side effects from tACS may include mild discomfort at the electrode sites on the scalp, tingling sensations during stimulation, fatigue after sessions or headaches. Serious side effects are rare but could involve seizure risk in susceptible individuals.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ before - after one single intervention (24 hour follow-up)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before - after one single intervention (24 hour follow-up)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Behavioral: interference rate
Neural: brain connectivity change
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active non-invasive brain stimulation during behavioral memory interferenceExperimental Treatment1 Intervention
Non-invasive brain stimulation with transcranial alternating current stimulation will be applied during a memory interference intervention.
Group II: Sham stimulation during behavioral memory interferencePlacebo Group1 Intervention
Inactive (sham) stimulation will be applied during a memory interference intervention.
Find a Location
Closest Location:Medical University of South Carolina· Charleston, SC· 525 miles
Who is running the clinical trial?
Medical University of South CarolinaLead Sponsor
990 Previous Clinical Trials
7,408,021 Total Patients Enrolled
Kirstin-Friederike Heise, PhDPrincipal InvestigatorMedical University of South Carolina
2 Previous Clinical Trials
444 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a neurological or psychiatric condition.I have an injury or disease affecting my scalp.I cannot use all ten fingers to type on a keyboard.I have had a brain tumor, brain infection, or abnormal brain blood vessels.I am 18 years or older.I have had brain radiotherapy before.I have had brain surgery before.I have a condition that makes it hard to type with all my fingers.I have never had a stroke, brain tumor, neurodegenerative disease, or serious head injury.I have had seizures in the past.I am not taking medications like carbamazepine that could affect learning or the study treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Active non-invasive brain stimulation during behavioral memory interference
- Group 2: Sham stimulation during behavioral memory interference
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.